September 10, 2018 08:58 AM EDT
People

SEC ac­cus­es biotech bil­lion­aire Phillip Frost of join­ing a 'pump-and-dump' scheme that net­ted $27M

John Carroll

Editor & Founder

Over the years Phillip Frost has ac­quired quite a rep­u­ta­tion in biotech. He chaired Te­va, man­ages Op­ko Health — and now has to con­tend with ac­cu­sa­tions …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

No­var­tis pays $150M up­front to Schrödinger in new drug deal, ramps up soft­ware use

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times